News
The firm said it is in discussions with the FDA to resubmit its biologics license application seeking approval for Ebvallo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback